Ambusol AB (publ)
559465-8303ActivePioneering patented therapy to eradicate residual glioblastoma cells post-surgery.
Oversigt
- 1–4
- Medarbejdere
- 100–149t SEK
- Omsætning
- 2023
- Grundlagt
Nøglebeslutningstagere
Göran Ronquist
Founder and board member
Owe Orwar
Senior Adviser to the board
Frederic Telander
Founder and chairman of the board
Holger Ronquist
Founder and board member
+2 flere kontakter i Funnelfeedr
Beskrivelse
Ambusol is a clinical-stage cancer therapeutics company focused on revolutionizing the treatment of glioblastoma (GBM). Their core mission is to eradicate residual GBM cells remaining in the surgical margins after operation, offering new hope to patients. The company pioneers a patented approach uti...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Tillverkning av läkemedel
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559465830301
Beslutningstagere
6 kontakter i FunnelfeedrGöran Ronquist
Founder and board member
Owe Orwar
Senior Adviser to the board
Frederic Telander
Founder and chairman of the board
Holger Ronquist
Founder and board member
Maximilian Telander
CEO, founder and board member
Gunnar Ronquist
Founder and board member
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrIsofol Medical AB (publ)
10–19 medarbejdereDeveloping next-generation folate drug to improve cancer treatment efficacy.
AcroPharma AB (publ)
0 medarbejdereDeveloping innovative preventive therapeutics for major human diseases.
Mendus AB (publ)
Developing immune-based cancer therapies to prevent recurrence.
Akiram Therapeutics AB
1–4 medarbejderePioneering targeted radioimmunotherapy to treat incurable solid tumors effectively.
AAX Biotech AB
5–9 medarbejdereResearch-driven biotech advancing antibody therapies via proprietary technology.
Udforsk mere
Spørgsmål om Ambusol AB (publ)
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo